
Diabetes
A short sentence to introduce what to expect in the about condition
section
Learn more
This is a multicenter, two-stage, randomized, controlled, open-label, Phase 3 study comparing the efficacy and safety of iberdomide in combination with dexamethasone and daratumumab (IberDd) versus daratumumab, bortezomib, and dexamethasone (DVd) in participants with relapsed or refractory multiple myeloma (RRMM).





Create an alert
The prescreener preview is complete. You may now close the preview.
